Epirubicin plus cyclophosphamide followed by docetaxel versus epirubicin plus docetaxel followed by capecitabine as adjuvant therapy for node-positive early breast cancer: Results from the GEICAM/2003-10 study
ISSN
0732183X
Date Issued
2015
Author(s)
DOI
10.1200/JCO.2015.61.9510
Subjects